Sweta Rani

Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes

Claire Corcoran, Sweta Rani, Keith O’Brien et al. · PLoS ONE · 2012 · 436 citations · Full text

Medicine, Oncology, Pharmacology +17

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

Keith O’Brien, Michelle C. Lowry, Claire Corcoran et al. · Oncotarget · 2015 · 271 citations · Full text

Medicine, Molecular Biology, Oncology +13

Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells

Keith O’Brien, Sweta Rani, Claire Corcoran et al. · European Journal of Cancer · 2013 · 248 citations · Full text

Medicine, Cell Biology, Oncology +14

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

Amanda O’Neill, Maria Prencipe, Catherine Dowling et al. · Molecular Cancer · 2011 · 248 citations · Full text

Medicine, Oncology, Pharmacology +17

miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

Claire Corcoran, Sweta Rani, Lorraine O’Driscoll · The Prostate · 2014 · 219 citations · Full text

Medicine, Molecular Biology, Oncology +17